Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

Name: Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
License: Public Domain

Children's Hospital Los Angeles

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pan safety

retinopathy of prematurity, pan-vascular endothelial growth factor blockade, safety, rop, bevacizumab, avastin, expanded access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 905594
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.